Donna Scroggin’s hormone replacement product liability suit against Wyeth and Upjohn has been quite a roller coaster ride. At the spring 2008 trial of Scroggin’s claim that the drug companies failed to warn of the increased risk of breast cancer resulting from their estrogen and progestin products, a Little Rock, Ark., federal district court jury awarded the breast cancer survivor $2.75 million in compensatory damages. In the second phase of trial, the jury hit Upjohn with about $8 million in punitive damages, and Wyeth with $19 million.

Those punies didn’t last long, though. After post-trial motions, Judge William Wilson Jr. upheld the jury’s liability finding and $2.75 million compensatory damages verdict against Wyeth and Upjohn. But he struck the testimony of Scroggin’s punitive damages expert and vacated the punitive damages awards against the drug companies.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]